Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Topic

Treatment (remove)
- HIV drugs (remove)
  - Efavirenz (Sustiva) (remove)
  - Darunavir (Prezista) (1)
- Side effects (4)
- Drug treatment strategies (1)
Emotional health (1)
Healthy living (1)
Organ and body health (1)

Filter by Infection

HIV (remove)

Filter by Resource Category

Search results

Current filters: HIV drugs, HIV, Treatment, Efavirenz (Sustiva)

6 search results

How might efavirenz affect the brain?: From TreatmentUpdate 204
2014, CATIE
Research summary - Webpage
Efavirenz and suicide risk: From TreatmentUpdate 204
2014, CATIE
Research summary - Webpage
France: Factors linked to low vitamin D levels in HIV-positive people: 2012, CATIE
Research summary - Webpage
Efavirenz (Sustiva): 2016, CATIE
Fact sheet - Webpage
Study finds replacing efavirenz with darunavir improves vitamin D levels: 2010, CATIE
Research summary - Webpage
Decreased levels of vitamin D may occur with efavirenz exposure: 2010, CATIE
Research summary - Webpage

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.